Technology News and Research

RSS

BioMimetic Therapeutics amends and restates its agreement with Novartis Vaccines and Diagnostics

BioMimetic Therapeutics, Inc. today announced that effective December 31, 2009, the Company amended and restated its manufacturing and supply agreement with Novartis Vaccines and Diagnostics, Inc. for the supply of bulk rhPDGF-BB to BioMimetic.

6 Jan 2010

Mayo Clinic research ends major controversy in cancer research

ChromoCure, Inc. (PINKSHEETS: KKUR) is pleased to announce the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell, along with an independent commentary on the discovery, end a major controversy in the field of cancer research as to whether aneuploidy is a cause or a consequence of cancer and further proves the aneuploidy basis of cancer.

6 Jan 2010

ORNL story tips for January 2010

World-class computing at Oak Ridge National Laboratory could be unleashed to save as much as $50 billion per year in fraud, waste and abuse in the nation's health care system.

6 Jan 2010

Ensemble Discovery initiates strategic alliance with Pfizer

Ensemble Discovery today announced the initiation of a strategic alliance with Pfizer Inc. to discover and develop drug candidates of a novel class against a number of high-value pharmaceutical targets.

6 Jan 2010

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK’s new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Gerhard Hindricks, Director, Electrophysiology Department at the Leipzig Heart Center in Leipzig, Germany.

6 Jan 2010

Similar effectiveness in treatment options for low-risk prostate cancer; research may help improve patient outcomes

A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably.

6 Jan 2010

Sg2: Demand for outpatient services to increase by nearly 22% over the next decade

Between now and 2019, the health care industry will see demand for outpatient services increase by nearly 22% while demand for inpatient services remains flat, according to Sg2, a future-focused health care information systems company. This will require hospitals to shift focus beyond the acute care center and look to services that span the care continuum.

6 Jan 2010

Center for Technology and Aging announces grants to improve medication use in older adults

The Center for Technology and Aging today announced grants to five organizations for projects that promise to help improve medication use in older adults with chronic health conditions.

6 Jan 2010

SMART Modular Technologies releases XceedIOPS SATA

SMART Modular Technologies (WWH), Inc. ("SMART" or the "Company"), a leading independent manufacturer of memory modules and solid-state storage products, including solid-state drives (SSDs), today announced the XceedIOPS SATA, its next-generation enterprise-class SSD.

6 Jan 2010

New research shows breast milk is not as important for mother or child's health

Feeling guilty that you didn't breastfeed your children enough - or at all? Relax. New research shows that breast milk is not as important for either the mother or the child's health.

6 Jan 2010

Agilent Technologies, Covaris sign co-marketing agreement to streamline next-generation sequencing experiments

Agilent Technologies, Inc. (NYSE:A) and Covaris Inc. today announced a co-marketing agreement in which Covaris S2 DNA shearing technology will be marketed with the Agilent SureSelect Target Enrichment System to streamline next-generation sequencing experiments.

6 Jan 2010

Untreated hearing loss can put personal safety and overall health at risk

With hearing loss in America approaching what medical researchers say may be epidemic proportions, a top hearing care executive is calling for this to be the year that hearing care is recognized as a medical necessity.

6 Jan 2010

Thomson Reuters' Clinical Xpert Navigator named in KLAS Awards

Thomson Reuters announced today that its Clinical Xpert((TM)) Navigator has been named the category leader for mobile data systems in the latest "Top 20 Best in KLAS Awards: Software & Professional Services" report.

6 Jan 2010

Innexus Biotechnology designs new psoriasis product

InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.

6 Jan 2010

UC San Diego bioengineering professor receives 2009 Presidential Science Prize

For Shu Chien - a pioneer in the growing field of bioengineering - understanding and learning the marvels of how the human body works has been the foundation of his decades-long quest to advance science and technology worldwide. The UC San Diego bioengineering professor's significant scientific endeavors have paved the way for recognition of his renowned work at the university's Jacobs School of Engineering and abroad.

6 Jan 2010

OncoMed Pharmaceuticals and Fluidigm announce new initiative to analyze tumor cell heterogeneity

OncoMed Pharmaceuticals, Inc. and Fluidigm Corporation today announced a new initiative to apply Fluidigm's unique microfluidic tools to the analysis of tumor cell heterogeneity, including cancer stem cells.

6 Jan 2010

Jumpstart and Portal Capital invest $500,000 in TheraVasc for PAD drug

JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, and Portal Capital, a Cleveland-based private equity firm investing in life science companies, each announce an investment commitment of $250,000 in TheraVasc Inc., for a total commitment of $500,000. The

6 Jan 2010

Pharsight releases Phoenix NLME and Phoenix Connect

Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, today announced that it has released two new data analysis tools; Phoenix NLME and Phoenix Connect.

6 Jan 2010

AMT receives Innovation Credit to develop gene therapy treatment for DMD

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it will receive an Innovation Credit of up to EUR 4 million from the Dutch government to support the development of AMT's gene therapy treatment for Duchenne Muscular Dystrophy (DMD).

6 Jan 2010

University of Montreal expands treatment capacity with EON Reality's simulations system

EON Reality, the world's leading interactive 3D software provider, today announced that the Visual Psychophysics and Perception Laboratory at the University of Montreal expands their treatment capacity with a fully immersive environment from EON Reality. A new simulations system for rehabilitation and training of athletic performance, developed by Professor Jocelyn Faubert's team, will be immersed within the EON Icube, a technology that allows virtual training in a natural and realistic environment.

6 Jan 2010

Technology News and Research

BioMimetic Therapeutics amends and restates its agreement with Novartis Vaccines and Diagnostics

Mayo Clinic research ends major controversy in cancer research

ORNL story tips for January 2010

Ensemble Discovery initiates strategic alliance with Pfizer

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

Similar effectiveness in treatment options for low-risk prostate cancer; research may help improve patient outcomes

Sg2: Demand for outpatient services to increase by nearly 22% over the next decade

Center for Technology and Aging announces grants to improve medication use in older adults

SMART Modular Technologies releases XceedIOPS SATA

New research shows breast milk is not as important for mother or child's health

Agilent Technologies, Covaris sign co-marketing agreement to streamline next-generation sequencing experiments

Untreated hearing loss can put personal safety and overall health at risk

Thomson Reuters' Clinical Xpert Navigator named in KLAS Awards

Innexus Biotechnology designs new psoriasis product

UC San Diego bioengineering professor receives 2009 Presidential Science Prize

OncoMed Pharmaceuticals and Fluidigm announce new initiative to analyze tumor cell heterogeneity

Jumpstart and Portal Capital invest $500,000 in TheraVasc for PAD drug

Pharsight releases Phoenix NLME and Phoenix Connect

AMT receives Innovation Credit to develop gene therapy treatment for DMD

University of Montreal expands treatment capacity with EON Reality's simulations system

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News